EdgarLookup

Pizzuti Dana

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to Pizzuti Dana. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

CRNX
Company Title Type Shares Price Value Date
CRNX Chief Med and Dev Officer Option Exercise 5,000 $16.89 $84,450 Dec 1, 2025
CRNX Chief Med and Dev Officer Sale 100 $43.27 $4,327 Nov 3, 2025
CRNX Chief Med and Dev Officer Option Exercise 5,000 $16.89 $84,450 Oct 1, 2025
CRNX Chief Med and Dev Officer Sale 5,000 $32.10 $160,500 Sep 2, 2025
CRNX Chief Med and Dev Officer Sale 30,000 $30.43 $912,900 Aug 22, 2025
CRNX Chief Med and Dev Officer Sale 6,492 $29.18 $189,437 Aug 20, 2025
CRNX Chief Med and Dev Officer Sale 127 $34.83 $4,423 Mar 19, 2025
CRNX Chief Med and Dev Officer Award / Grant 43,000 Feb 20, 2025
CRNX Chief Med and Dev Officer Sale 5,000 $39.07 $195,350 Feb 3, 2025
CRNX Chief Med and Dev Officer Option Exercise 2,500 $19.64 $49,100 Jan 3, 2025
CRNX Chief Med and Dev Officer Sale 14,375 $54.63 $785,306 Oct 3, 2024
CRNX Chief Med and Dev Officer Option Exercise 14,375 $16.89 $242,794 Jul 3, 2024
CRNX Chief Med and Dev Officer Option Exercise 9,500 $16.89 $160,455 Jun 24, 2024
CRNX Chief Med and Dev Officer Option Exercise 14,375 $16.89 $242,794 Apr 15, 2024
CRNX Chief Med and Dev Officer Sale 714 $43.69 $31,195 Mar 20, 2024
CRNX Chief Med and Dev Officer Tax Withholding 411 $38.14 $15,676 Mar 18, 2024
CRNX Chief Med and Dev Officer Award / Grant 23,000 Mar 4, 2024
CRNX Chief Med and Dev Officer Sale 14,375 $35.00 $503,125 Jan 3, 2024
CRNX Chief Med and Dev Officer Sale 9,583 $34.57 $331,284 Dec 21, 2023
CRNX Chief Development Officer Sale 8,212 $16.15 $132,624 Apr 3, 2023
CRNX Chief Development Officer Award / Grant 4,500 Mar 1, 2023
CRNX Chief Development Officer Award / Grant 12,500 Oct 10, 2022